Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-04-002979
Filing Date
2004-03-15
Accepted
2004-03-15 16:44:11
Documents
16
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 1427150
3 v02027_ex10-40.txt EX-10.40 29151
4 v01990_ex10-41.txt EX-10.41 28240
5 v01990_ex10-42.txt EX-10.42 28370
6 v2027_ex10-4.txt EX-10.43 2417
7 v02027_ex10-44.txt EX-10.44 11779
8 v02027_ex10-45.txt EX-10.45 13255
9 v02027_ex10-46.txt EX-10.46 6564
10 v02027_ex14-1.txt EX-14.1 14392
11 v02027_ex14-2.txt EX-14.2 6129
12 ex23-2.txt EX-23.1 597
13 ex23-3.txt EX-23.2 560
14 ex31_1.txt EX-31.1 2897
15 v02027_ex31-2.txt EX-31.2 2899
16 v02027_ex32-1.txt EX-32.1 1563
17 ex32_2.txt EX-32.2 1503
  Complete submission text file 0001144204-04-002979.txt   1580282
Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Filer) CIK: 0001066833 (see all company filings)

EIN.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-49730 | Film No.: 04670068
SIC: 2834 Pharmaceutical Preparations